Biocon enters into business transfer agreement with BBIL

24 Jan 2018 Evaluate

Biocon has entered into a Business Transfer Agreement (BTA) with its step down wholly owned subsidiary, Biocon Biologics India (BBIL) on January 22, 2018, for the transfer of its Biosimilars business to BBIL.

The proposed transfer of Biosimilars business would enable consolidation of the development, commercialization and manufacturing of all Biosimilars businesses under a single structure.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.


Biocon Share Price

377.55 -1.50 (-0.40%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×